C D = C (1.03 −LE ) C D = discounted cost; C = undiscounted cost; LE = life expectancy of study group Discount rate can be altered by changing value (eg, for 5%, use 1.05) Utility y = −0.0479x 3 ϩ 0.191x 2 − 0.4233x ϩ 0.9128 y = Utility value; x = visual acuity (logMAR units)
If the data were usable, they were kept; otherwise they were discarded. Scopus Cost ϩ cataract surgery (2006) (2007) If the data were usable and did not duplicate MEDLINE data, they were kept; otherwise they were discarded. Google Cost ϩ cataract surgery ϩ country (eg, Nepal) (2006) (2007) If data came from a peer-reviewed source and were usable, they were kept; otherwise they were discarded. If the data came from a reliable government source and were usable, they were kept; otherwise they were discarded. If the data source was authored by a person who had published in other ophthalmology/health economics journals and the data were usable, they were kept; otherwise they were discarded. Calculates utility values in each study from corresponding preoperative and postoperative visual acuities a Cost utility (discounted for both costs and quality-adjusted life-year gain)
C D = discounted cost (3% in the base case); U 2 = postoperative utility; U 1 = preoperative utility; L = life expectancy of the study cohort; r = discount rate (3% in base case) a The justification for using a polynomial instead of a linear equation is that at both ends of the scale with regard to (1) severe blindness impairment and (2) near normal vision, the utility value is nonlinear with respect to visual acuity. Data of Kobelt et al 1 show a similar curve.
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